
Axonics Investor Relations Material
Latest events

Q3 2023
Axonics

Q3 2024
7 Nov, 2024

Q2 2024
1 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Axonics Inc
Access all reports
Axonics, Inc. is a medical technology company specializing in implantable devices for the treatment of bladder and bowel dysfunction. The company develops and markets sacral neuromodulation systems designed to provide long-term relief for patients with conditions such as overactive bladder, urinary retention, and fecal incontinence. Axonics focuses on innovative, patient-friendly solutions that enhance the quality of life and offer alternatives to traditional treatments. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
AXNX
Country
🇺🇸 United States